![PRD_002452 PRD_002452](https://data.pdbj.org/pdbjplus/data/cc/svg/TKP.svg) | PRD_002452 | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C27 H40 Cl N3 O5 | Definition date: | 2020-10-14 | Last modified: | 2020-10-14 |
|
![PRD_002456 PRD_002456](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002456.svg) | PRD_002456 | Name: | ecumicin | Formula: | C83 H135 N14 O17 | Definition date: | 2020-12-30 | Last modified: | 2023-11-03 |
|
![PRD_900134 PRD_900134](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_900134.svg) | PRD_900134 | Name: | Blood group B H type 2 antigen, beta anomer | Formula: | C26 H45 N O20 | Description: | oligosaccharide with branches | Definition date: | 2021-02-17 | Last modified: | 2021-02-17 |
|
![PRD_002460 PRD_002460](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002460.svg) | PRD_002460 | Formula: | C20 H39 N3 O5 | Description: | Calpain I inhibitor | Definition date: | 2021-02-24 | Last modified: | 2021-02-24 |
|
![PRD_002360 PRD_002360](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002360.svg) | PRD_002360 | Name: | myristoyl thiourea inhibitor, No. 23 | Formula: | C37 H67 N9 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
![PRD_002361 PRD_002361](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002361.svg) | PRD_002361 | Name: | myristoyl thiourea inhibitor, No.13 | Formula: | C39 H73 N12 O5 S | Definition date: | 2021-03-24 | Last modified: | 2021-03-24 |
|
![PRD_002397 PRD_002397](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002397.svg) | PRD_002397 | Formula: | C41 H72 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002398 PRD_002398](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002398.svg) | PRD_002398 | Formula: | C42 H74 N14 O10 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002399 PRD_002399](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002399.svg) | PRD_002399 | Formula: | C45 H68 N10 O11 S | Definition date: | 2021-03-31 | Last modified: | 2021-03-31 |
|
![PRD_002330 PRD_002330](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002330.svg) | PRD_002330 | Name: | Darobactin | Formula: | C47 H56 N11 O12 | Definition date: | 2021-04-21 | Last modified: | 2023-06-11 |
|
![PRD_002362 PRD_002362](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002362.svg) | PRD_002362 | Name: | GsIN-1 peptide | Formula: | C79 H106 N16 O21 S | Definition date: | 2021-04-21 | Last modified: | 2021-04-21 |
|
![PRD_002377 PRD_002377](https://data.pdbj.org/pdbjplus/data/cc/svg/U5Y.svg) | PRD_002377 | Name: | (12S,15S)-N-[(2-fluorophenyl)methyl]-10,13-dioxo-12-{2-oxo-2-[(2R)-2-phenylpyrrolidin-1-yl]ethyl}-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxamide | Formula: | C39 H39 F N4 O5 | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
![PRD_002383 PRD_002383](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002383.svg) | PRD_002383 | Name: | des4.3.1 | Formula: | C44 H74 N12 O11 S | Definition date: | 2021-04-28 | Last modified: | 2021-04-28 |
|
![PRD_002457 PRD_002457](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002457.svg) | PRD_002457 | Name: | beta-D-glucopyranose-(1-4)-beta-D-glucopyranose-(1-3)-2-deoxy-2-fluoro-alpha-D-glucopyranose | Formula: | C18 H31 F O15 | Definition date: | 2021-05-19 | Last modified: | 2021-05-19 |
|
![PRD_002459 PRD_002459](https://data.pdbj.org/pdbjplus/data/cc/svg/LMO.svg) | PRD_002459 | Name: | dodecyl 6-O-alpha-D-galactopyranosyl-beta-D-glucopyranoside | Formula: | C24 H46 O11 | Definition date: | 2021-08-04 | Last modified: | 2021-08-04 |
|
![PRD_002346 PRD_002346](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002346.svg) | PRD_002346 | Name: | Inhibitor ARC-3126 | Formula: | C58 H108 Br N31 O9 S | Definition date: | 2021-08-04 | Last modified: | 2023-06-11 |
|
![PRD_002350 PRD_002350](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002350.svg) | PRD_002350 | Name: | INHIBITOR ARC-1415 | Formula: | C55 H106 N30 O8 | Definition date: | 2021-08-04 | Last modified: | 2023-11-03 |
|
![PRD_002469 PRD_002469](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002469.svg) | PRD_002469 | Name: | Inhibitor 18 | Formula: | C30 H42 N4 O6 | Definition date: | 2021-08-25 | Last modified: | 2021-08-25 |
|
![PRD_002454 PRD_002454](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002454.svg) | PRD_002454 | Name: | Substrate-like cysteine protease inhibitor | Formula: | C46 H70 Cl N10 O9 | Definition date: | 2021-09-01 | Last modified: | 2021-09-01 |
|
![PRD_002482 PRD_002482](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002482.svg) | PRD_002482 | Name: | cyclic peptide MP-9903 | Formula: | C71 H108 N17 O20 S2 | Definition date: | 2021-09-22 | Last modified: | 2023-11-03 |
|
![PRD_002455 PRD_002455](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002455.svg) | PRD_002455 | Name: | D-PMI-omega | Formula: | C82 H115 Cl N17 O20 | Definition date: | 2021-11-17 | Last modified: | 2021-11-17 |
|
![PRD_002366 PRD_002366](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002366.svg) | PRD_002366 | Name: | Phalloidin | Formula: | C35 H48 N8 O11 S | Definition date: | 2021-12-22 | Last modified: | 2023-05-09 |
|
![PRD_002479 PRD_002479](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002479.svg) | PRD_002479 | Name: | Cyclic Peptide Inhibitor ZO1-GLN-SER-TPO-45W-MLL | Formula: | C34 H48 F3 N6 O14 P | Definition date: | 2022-03-02 | Last modified: | 2022-03-02 |
|
![PRD_002486 PRD_002486](https://data.pdbj.org/pdbjplus/data/cc/svg/83E.svg) | PRD_002486 | Name: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[([1,1'-biphenyl]-4-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide | Formula: | C49 H67 N5 O6 | Definition date: | 2022-03-02 | Last modified: | 2022-03-02 |
|
![PRD_002487 PRD_002487](https://data.pdbj.org/pdbjplus/data/cc/svg/83K.svg) | PRD_002487 | Name: | N,N-dimethyl-L-valyl-L-leucyl-N-[(3S)-6-{(2S)-2-[(1H-indol-3-yl)methyl]-3-methoxy-5-oxo-2,5-dihydro-1H-pyrrol-1-yl}-6-oxo-1-phenylhexan-3-yl]-L-leucinamide | Formula: | C45 H64 N6 O6 | Definition date: | 2022-03-02 | Last modified: | 2022-03-02 |
|